Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Bone
|
August 12, 2015
Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats
Michael S Ominsky, Danielle L Brown, Gwyneth Van, et al.
Endocrinology
|
September 27, 2014
Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody
Xiaodong Li, Qing-Tian Niu, Kelly S Warmington, et al.
Bone
|
June 23, 2009
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
Xiaodong Li, Michael S Ominsky, Marina Stolina, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial
Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2010
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
Xiaodong Li, Kelly S Warmington, Qing-Tian Niu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 25, 2008
RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats
Michael S Ominsky, Xiaodong Li, Frank J Asuncion, et al.
Bone
|
September 5, 2017
Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism
Xiaodong Li, Longchuan Yu, Frank Asuncion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 5, 2009
One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength
Michael S Ominsky, Marina Stolina, Xiaodong Li, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 10, 2010
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies
Ian R Reid, Paul D Miller, Jacques P Brown, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 10, 2016
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
Xiaodong Li, Shanaka Stanislaus, Frank Asuncion, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Bone
|
August 12, 2015
Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats
Michael S Ominsky, Danielle L Brown, Gwyneth Van, et al.
Endocrinology
|
September 27, 2014
Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody
Xiaodong Li, Qing-Tian Niu, Kelly S Warmington, et al.
Bone
|
June 23, 2009
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
Xiaodong Li, Michael S Ominsky, Marina Stolina, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial
Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 20, 2010
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
Xiaodong Li, Kelly S Warmington, Qing-Tian Niu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 25, 2008
RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats
Michael S Ominsky, Xiaodong Li, Frank J Asuncion, et al.
Bone
|
September 5, 2017
Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism
Xiaodong Li, Longchuan Yu, Frank Asuncion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 5, 2009
One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength
Michael S Ominsky, Marina Stolina, Xiaodong Li, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 10, 2010
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies
Ian R Reid, Paul D Miller, Jacques P Brown, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 10, 2016
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
Xiaodong Li, Shanaka Stanislaus, Frank Asuncion, et al.
Page
of 9